Short-Term Systemic AEs After COVID-19 mRNA Vaccination May Be Indicative Of Increased Long-Lasting nAb Responses, Study Suggests

July 10, 2024

Infectious Disease Advisor (7/9, Nye) reports, “Short-term systemic adverse effects (AEs) after COVID-19 mRNA vaccination may be indicative of increased long-lasting neutralizing antibody (nAb) responses, according to results of a study.” Overall, “for every additional symptom that occurred after receipt of the second vaccine dose, the researchers observed a 1.10-fold higher ID50 nAb response.” The findings were published in the Annals of Internal Medicine.